The incidence of both serious and minor complications in young women undergoing oocyte donation

Fertility and Sterility

Volumn 90, Issue 6, 2008, Pages 2165-2171

  Maxwell, Kara N ^a   Cholst, Ina N ^b   Rosenwaks, Zev ^b  

^a Columbia University ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

ART complications; egg donation; informed consent; IVF; Oocyte donation

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEMALE INFERTILITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; OOCYTE DONATION; OOCYTE RETRIEVAL; OVARY CYST; OVARY DISEASE; OVARY HYPERSTIMULATION; OVARY TORSION; PRIORITY JOURNAL; RECURRENT DISEASE; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION;

ADULT; COMMUNICABLE DISEASES; FEMALE; HUMANS; INCIDENCE; INFORMED CONSENT; OOCYTE DONATION; OOCYTE RETRIEVAL; OVARIAN CYSTS; OVARIAN DISEASES; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RUPTURE; SEVERITY OF ILLNESS INDEX; TISSUE DONORS; TORSION ABNORMALITY; YOUNG ADULT;

EID: 56649124494     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.10.065     Document Type: Article

References (29)

1. Van Voorhis B.J. Clinical practice. In vitro fertilization. N Engl J Med 356 (2007) 379-386
2. Wright V.C., Chang J., Jeng G., and Macaluso M. Assisted reproductive technology surveillance-United States, 2003. MMWR Surveill Summ 55 (2006) 1-22
3. Centers for Disease Control and Prevention. 2004 Assisted reproductive technology success rates: national summary and fertility clinic reports (2006), U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA
4. Rosenwaks Z. Donor eggs: their application in modern reproductive technologies. Fertil Steril 47 (1987) 895-909
5. Tarlatzis B.C., and Pados G. Oocyte donation: clinical and practical aspects. Mol Cell Endocrinol 161 (2000) 99-102
6. Soderstrom-Anttila V. Pregnancy and child outcome after oocyte donation. Hum Reprod Update 7 (2001) 28-32
7. Kalfoglou A.L. Navigating conflict of interest in oocyte donation. Am J Bioeth 1 (2001) W1. Available at: http://www.bioethics.net/journal/j_articles.php?aid=334
8. Robertson J.A. Ethical and legal issues in human embryo donation. Fertil Steril 64 (1995) 885-894
9. Resnik D.B. The commodification of human reproductive materials. J Med Ethics 24 (1998) 388-393
10. Lidz C.W., Appelbaum P.S., Grisso T., and Renaud M. Therapeutic misconception and the appreciation of risks in clinical trials. Soc Sci Med 58 (2004) 1689-1697
11. Mastroianni L. Risk evaluation and informed consent for ovum donation: a clinical perspective. Am J Bioeth 1 (2001) 28-29
12. Practice Committee of the American Society for Reproductive Medicine. Repetitive oocyte donation. Fertil Steril 82 Suppl 1 (2004) S158-S159
13. Sauer M.V. Defining the incidence of serious complications experienced by oocyte donors: a review of 1000 cases. Am J Obstet Gynecol 184 (2001) 277-278
14. Davis O.K., and Rosenwaks Z. Superovulation strategies for assisted reproductive technologies. Semin Reprod Med 19 (2001) 207-212
15. Damario M.A., Barmat L., Liu H.C., Davis O.K., and Rosenwaks Z. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients. Hum Reprod 12 (1997) 2359-2365
16. Benadiva C.A., Davis O., Kligman I., Moomjy M., Liu H.C., and Rosenwaks Z. Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertil Steril 67 (1997) 724-727
17. Golan A., Ron-el R., Herman A., Soffer Y., Weinraub Z., and Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 44 (1989) 430-440
18. Delvigne A., and Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update 8 (2002) 559-577
19. Abramov Y., Elchalal U., and Schenker J.G. Severe OHSS: an "epidemic" of severe OHSS: a price we have to pay?. Hum Reprod 14 (1999) 2181-2183
20. Govaerts I., Devreker F., Delbaere A., Revelard P., and Englert Y. Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. Eur J Obstet Gynecol Reprod Biol 77 (1998) 239-243
21. Roest J., Mous H.V., Zeilmaker G.H., and Verhoeff A. The incidence of major clinical complications in a Dutch transport IVF programme. Hum Reprod Update 2 (1996) 345-353
22. Serour G.I., Aboulghar M., Mansour R., Sattar M.A., Amin Y., and Aboulghar H. Complications of medically assisted conception in 3,500 cycles. Fertil Steril 70 (1998) 638-642
23. Sauer M.V., and Kavic S.M. Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy. Reprod Biomed Online 12 (2006) 153-162
24. Sauer M.V., and Paulson R.J. Mishaps and misfortunes: complications that occur in oocyte donation. Fertil Steril 61 (1994) 963-965
25. Sauer M.V., Paulson R.J., and Lobo R.A. Rare occurrence of ovarian hyperstimulation syndrome in oocyte donors. Int J Gynaecol Obstet 52 (1996) 259-262
26. Halme J., Toma S.K., and Talbert L.M. A case of severe ovarian hyperstimulation in a healthy oocyte donor. Fertil Steril 64 (1995) 857-859
27. Rosenberg H., and Epstein Y. Follow-up study of anonymous ovum donors. Hum Reprod 10 (1995) 2741-2747
28. Kalfoglou A.L., and Gittelsohn J. A qualitative follow-up study of women's experiences with oocyte donation. Hum Reprod 15 (2000) 798-805
29. Sung L., Bustillo M., Mukherjee T., Booth G., Karstaedt A., and Copperman A.B. Sisters of women with premature ovarian failure may not be ideal ovum donors. Fertil Steril 67 (1997) 912-916